Aethlon Medical, Inc. (NASDAQ:AEMD – Get Free Report) was the recipient of a large growth in short interest during the month of April. As of April 15th, there was short interest totalling 29,800 shares, a growth of 57.7% from the March 31st total of 18,900 shares. Approximately 1.3% of the shares of the company are short sold. Based on an average daily trading volume, of 8,200 shares, the short-interest ratio is presently 3.6 days.
Analyst Ratings Changes
Several research firms have commented on AEMD. HC Wainwright dropped their price objective on shares of Aethlon Medical from $23.00 to $10.00 and set a “buy” rating on the stock in a report on Monday, March 4th. StockNews.com assumed coverage on Aethlon Medical in a research note on Sunday. They set a “sell” rating for the company.
View Our Latest Stock Analysis on Aethlon Medical
Aethlon Medical Stock Down 9.5 %
Aethlon Medical (NASDAQ:AEMD – Get Free Report) last announced its quarterly earnings data on Wednesday, February 14th. The medical equipment provider reported ($1.37) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($1.23) by ($0.14). As a group, research analysts expect that Aethlon Medical will post -4.98 EPS for the current fiscal year.
About Aethlon Medical
Aethlon Medical, Inc, a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses and use in organ transplantation.
See Also
- Five stocks we like better than Aethlon Medical
- Bank Stocks – Best Bank Stocks to Invest In
- Snap Crackles and Pops on Surprise Profit and Raised Guidance
- Upcoming IPO Stock Lockup Period, Explained
- MarketBeat Week in Review – 4/22 – 4/26
- What is a Dividend King?
- 3 Stocks Leading the U.S. Agriculture Comeback
Receive News & Ratings for Aethlon Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aethlon Medical and related companies with MarketBeat.com's FREE daily email newsletter.